Literature DB >> 24091534

To target or not to target the enemy within localized prostate cancer.

Gail Risbridger1, Renea Taylor.   

Abstract

Entities:  

Keywords:  androgen withdrawal; castration; cellular targets; prostate cancer

Mesh：

Year:  2013        PMID： 24091534      PMCID： PMC3895420          DOI： 10.4161/cc.26576

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  8 in total

1.  Tissue slice grafts: an in vivo model of human prostate androgen signaling.

Authors:  Hongjuan Zhao; Rosalie Nolley; Zuxiong Chen; Donna M Peehl
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.

Authors:  Markus Germann; Antoinette Wetterwald; Natalia Guzmán-Ramirez; Gabri van der Pluijm; Zoran Culig; Marco G Cecchini; Elizabeth D Williams; George N Thalmann
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

Review 3.  Breaking through a roadblock in prostate cancer research: an update on human model systems.

Authors:  R Toivanen; R A Taylor; D W Pook; S J Ellem; G P Risbridger
Journal:  J Steroid Biochem Mol Biol       Date:  2012-02-08       Impact factor: 4.292

4.  Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process.

Authors:  N Craft; C Chhor; C Tran; A Belldegrun; J DeKernion; O N Witte; J Said; R E Reiter; C L Sawyers
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

Review 5.  Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer.

Authors:  Karen E Knudsen; Trevor M Penning
Journal:  Trends Endocrinol Metab       Date:  2010-02-06       Impact factor: 12.015

6.  Establishment and genomic characterization of mouse xenografts of human primary prostate tumors.

Authors:  Carmen Priolo; Michelle Agostini; Natalie Vena; Azra H Ligon; Michelangelo Fiorentino; Eyoung Shin; Antonella Farsetti; Alfredo Pontecorvi; Ewa Sicinska; Massimo Loda
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

7.  Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.

Authors:  Jennifer A Locke; Emma S Guns; Amy A Lubik; Hans H Adomat; Stephen C Hendy; Catherine A Wood; Susan L Ettinger; Martin E Gleave; Colleen C Nelson
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

8.  The mutational landscape of lethal castration-resistant prostate cancer.

Authors:  Catherine S Grasso; Yi-Mi Wu; Dan R Robinson; Xuhong Cao; Saravana M Dhanasekaran; Amjad P Khan; Michael J Quist; Xiaojun Jing; Robert J Lonigro; J Chad Brenner; Irfan A Asangani; Bushra Ateeq; Sang Y Chun; Javed Siddiqui; Lee Sam; Matt Anstett; Rohit Mehra; John R Prensner; Nallasivam Palanisamy; Gregory A Ryslik; Fabio Vandin; Benjamin J Raphael; Lakshmi P Kunju; Daniel R Rhodes; Kenneth J Pienta; Arul M Chinnaiyan; Scott A Tomlins
Journal:  Nature       Date:  2012-07-12       Impact factor: 49.962
  8 in total
  1 in total

1.  Over-Expression of Activin-βC Is Associated with Murine and Human Prostate Disease.

Authors:  Edward C Ottley; Karen L Reader; Kailun Lee; Francesco E Marino; Helen D Nicholson; Gail P Risbridger; Elspeth Gold
Journal:  Horm Cancer       Date:  2017-01-23       Impact factor: 3.869
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.